Imagenebio Inc stock is traded at $4.17, with a volume of 15,946. It is up +1.59% in the last 24 hours and down -9.46% over the past month. ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
Previous Close:
$4.10
Open:
$4.00
24h Volume:
15,946
Relative Volume:
1.37
Market Cap:
$47.28M
Revenue:
$800.00K
Net Income/Loss:
-$45.07M
P/E Ratio:
-
EPS:
-$5.26
Net Cash Flow:
-$52.08M
1W Performance:
+1.59%
1M Performance:
-9.46%
6M Performance:
-31.50%
1Y Performance:
-50.36%
1-Day Range:
$0.00$0.00
1-Week Range:
$3.89$4.25
52-Week Range:
$3.88$8.84
Imagenebio Inc Stock (IMA) Company Profile
Name
Imagenebio IncSector
HealthcareIndustry
BiotechnologyPhone
857-343-8292Address
12526 HIGH BLUFF DRIVE, SAN DIEGO, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS